United States News Todas as matérias

Pasithea Therapeutics (NASDAQ:KTTA) reported positive interim Phase 1 clinical trial results for PAS-004, an oral MEK inhibitor being tested in advanced MAPK pathway-driven solid tumors, including patients previously treated with MEK and BRAF inhibitors.

Novocure (NASDAQ:NVCR) said its Optune Pax device has received CE Mark approval for treating adult patients with locally advanced pancreatic cancer of exocrine origin in combination with gemcitabine and nab-paclitaxel.

Redwire (NYSE:RDW) announced it has been awarded a contract by Taiwan Color Optics, a subsidiary of SemiLux International, to deliver its Penguin Mk2.5 VTOL uncrewed aerial system to the Taiwan Coast Guard.

Webull (NASDAQ:BULL), through its subsidiary Webull Thailand, signed an agreement to acquire Pi Securities, a Thai investment services firm with more than 50 years of market experience.

Ingredion (NYSE:INGR) completed the sale of a 51% equity interest in its Pakistan business, Rafhan Maize, for approximately $165 million.

Merck (NYSE:MRK) and AbbVie (NYSE:ABBV) are facing U.S. national security investigations over their clinical trial activities in China.

Santacruz Silver Mining (NASDAQ:SCZM) reported that an employee died following an incident at its Reserva mine in Bolivia on June 24, 2026.

Magnachip Semiconductor (NYSE:MX) appointed Chae Lee as Chief Executive Officer, effective July 1, 2026, marking a leadership change after nearly 11 months under interim CEO Camillo Martino.

Oklo (NYSE:OKLO) announced that it has acquired Creative Engineers, an industry leader in chemical process engineering with extensive expertise in sodium and alkali-metal systems.

BeOne Medicines (NASDAQ:ONC) announced positive topline results from the Phase 3 MANGROVE study evaluating BRUKINSA plus rituximab versus bendamustine plus rituximab in adult patients with previously untreated mantle cell lymphoma.

Britain’s competition regulator proposed allowing app developers to steer users to alternative payment options outside Apple and Google app stores to reduce fees and boost competition.

Nike (NYSE:NKE) reported fourth quarter fiscal 2026 revenue of $11 billion, down 1% on a reported basis and down 4% on a currency-neutral basis.

Intrusion (NASDAQ:INTZ) said it has completed its acquisition of VigilAigent, a managed security service provider previously owned by Tego Cyber.

Progress Software (NASDAQ:PRGS) reported second quarter fiscal 2026 revenue of $253 million, an increase of 7% year over year on an actual currency basis and 6% on a constant currency basis.

Innovent Biologics and Lilly (NYSE:LLY) entered a commercialization agreement for Verzenios (abemaciclib) in mainland China, shifting commercial control to Innovent.

Hafnia (NYSE:HAFN) said Chief Executive Officer Mikael Skov will step down on 1 September 2026, with EVP Søren Steenberg Jensen appointed as his successor.

Evotec (NASDAQ:EVO) launched J.TRAIN, a turnkey biologics manufacturing model designed to place its continuous manufacturing technology inside partner-owned facilities.

Cal-Maine Foods (NASDAQ:CALM) said it has reached an agreement to resolve claims brought by the U.S. Department of Justice and 17 state attorneys general following a 15-month investigation into egg pricing practices.

QXO (NYSE:QXO) said its stockholders approved the issuance of shares needed to complete its acquisition of TopBuild (NYSE:BLD), alongside separate approval from TopBuild shareholders for the merger agreement.

Hormel Foods (NYSE:HRL) entered a definitive agreement to sell its Brazilian operations, which operate under the CERATTI brand, to Zanchetta Alimentos LTDA.

Genco Shipping & Trading (NYSE:GNK) said its board has unanimously rejected Diana Shipping’s extended unsolicited $24.80 per-share cash tender offer, saying it undervalues the company.

Air T (NASDAQ:AIRT) reported fiscal 2026 revenue of $327.1 million, compared with $291.5 million a year earlier, reflecting 12% growth that included contributions from its Rex acquisition.

Gilat Satellite Networks (NASDAQ:GILT) said it secured $43 million in new orders for its Sidewinder electronically steered antenna (ESA) terminals from a major in-flight connectivity service provider.

REGENXBIO (NASDAQ:RGNX) said it has dosed the first patient in the Phase IIb/III NAAVIGATE trial evaluating surabgene lomparvovec in diabetic retinopathy using suprachoroidal delivery.